DMA110: Demystifying Market Access in the South African Healthcare Environment
Key knowledge for those in the med-tech space who wish to introduce new technologies into South Africa
Introducing new technologies into the South African health care market can be daunting. Funders and other stakeholders manage prioritisation, utilisation, and health care costs through tools such as the Health Technology Assessment (HTA). Medical device registration, FDA certification and CE Mark, are critical quality, safety and efficacy indicators, but are merely authorizations to enter a particular market. They represent an absolute minimum requirement for market access but are not a guarantee for adoption and/or reimbursement. Policy makers and funders demand more!
Despite its market access focus, this course it not exclusively for market access personnel. Every level of business decision-maker will benefit by attending, learning to navigate these hurdles efficiently within resource constrained businesses.